Market Trends of Global Cervical Total Disc Replacement (CTDR) Industry
This section covers the major market trends shaping the Cervical Total Disc Replacement (CTDR) Market according to our research experts:
Metal on a Biocompatible Material (M-o-B) is Expected to Witness Significant Growth Over the Forecast Period
Metal on a Biocompatible Material (M-o-B) such as titanium, tantalum, zirconium, cobalt-nickel-chromium-molybdenum, and chromium-cobalt-molybdenum are widely used in artificial disc surgeries. In terms of biocompatibility, corrosion resistance, and Young's modulus, titanium is superior. The selection of biomaterials used is based on their physiologic resistance to mechanical loading, biocompatibility, and appropriate durability. Due to its biocompatibility and super corrosion resistance properties, this type of segment accounted for the highest market growth over the forecast period.
In March 2020, the National Library of Medicine published an article stating that the ProDisc-C implants are made of an alloy of cobalt, chromium, and molybdenum with ultra-high molecular weight polyethylene and a rough titanium surface coating. In the late stages of recovery from surgery, ProDisc-C has been observed to return the complete neck's range of motion to its preoperative condition. It was also claimed that patients with ProDisc-C replacement had segmental degenerative kyphosis greatly rectified.
North America is Expected to Dominate the Cervical Total Disc Replacement Market
North America is expected to dominate the cervical disc replacement market owing to high in the usage of devices and the increase in the prevalence of cervical degenerative disorders in the region. For instance, according to the Spine Center at Bone & Joint Clinic of Baton Rouge, one or more spinal discs have deteriorated in about 40% of persons over the age of 40. The common degenerative cervical disorders in North America include cervical spinal stenosis, cervical disc herniation, and cervical spondylosis.
The high concentration of market players and approvals of advanced cervical disc in the United States is some of the factors driving the growth of the cervical disc replacement devices market in the country. In April 2021, NuVasive received approval from the United States Food and Drug Administration (FDA) for Simplify Cervical Artificial Disc (Simplify Disc) for two-level cervical total disc replacement (cTDR). These continuous product launches and approvals in the region are anticipated to drive the growth of the market in the region.
Therefore, owing to the aforesaid factors the growth of the studied market is anticipated in the North America Region.
